Posters

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30

Sunday, September 28

4:45 PM - 6:00 PM PT

2341 - Real-World Data of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer Patients
Speaker: Cheng, Hao-Shen, MD - Taichung Veterans General Hospital, Taichung, Taichung
4:45 PM - 6:00 PM PT

2342 - Post Radiotherapy Lymphocyte Dynamics and Dose Constraints in Locally Advanced Thoracic Malignancies Undergoing Radical Radiotherapy
Speaker: Cheung, Ben Man Fei, MD - Queen Mary Hospital, Hong Kong, Hong Kong
4:45 PM - 6:00 PM PT

2343 - Treatment Outcomes of High-Dose Hypofractionated Palliative Radiotherapy (40 Gy in 10 daily fractions) for Non-Small Cell Lung Cancer
Speaker: Chow, James, MBChB - Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR
4:45 PM - 6:00 PM PT

2344 - Topical Honeysuckle Flower Gel for Radiation Dermatitis: A Novel Approach to Prevention and Management
Speaker: Chu, Chin-Nan, MD, PhD - Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan, R.O.C., Taichung, Taichung
4:45 PM - 6:00 PM PT

2345 - A Prospective, Phase II, Single-Arm Trial Evaluating Efficacy and Safety of the Regimen of Induction Cadonilimab plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Cadonilimab Therapy for Unresectable Stage III NSCLC
Speaker: CHU, Li - FUDAN UNIVERSITY SHANGHAI CANCER CENTER, SHANGHAI
4:45 PM - 6:00 PM PT

2346 - Toxicities of Brain and Spinal Cord Photon and Proton Radiation in Pediatric Brain Tumors Assessed by Real-World Data (RWD)
Speaker: Craig, Brandon, MD, PhD - University of Calgary, Calgary, AB
4:45 PM - 6:00 PM PT

2347 - Stereotactic Body Radiotherapy for the Treatment of Oligometastases Located in the Peritoneum or in the Abdominal Wall: Preliminary Results from a Mono-Institutional Analysis
Speaker: Cuccia, Francesco, MD - ARNAS - Civico Hospital, Palermo, PA
4:45 PM - 6:00 PM PT

2348 - Biology-Guided Radiotherapy for Lung and Bone Tumors: Early Insights into Local Control Outcomes from the Prospective Premier Registry
Speaker: Dan, Tu, MD - UTSW, Dallas, TX
4:45 PM - 6:00 PM PT

2349 - Representativeness and Generalizability of NCI-Funded Multi-Modality Randomized Clinical Trials (RCTs): A Case Study of Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Based on RTOG-0617 and the National Cancer Database (NCDB)
Speaker: de Sousa, Cecilia, MD, MPH - Johns Hopkins Medicine, Baltimore, MD
4:45 PM - 6:00 PM PT

2350 - Treatment Approach in Childhood Ewing Sarcoma - TROD Hematology Oncology Pediatric Oncology Total Body Irradiation Working Group Survey Study
Speaker: Demiroz, Candan, MD, RT - Bursa Uludag University Faculty of Medicine, Bursa, BURSA
4:45 PM - 6:00 PM PT

2351 - Efficacy and Safety of Oral Chemotherapy Concurrent Radiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer after Neoadjuvant Chemoimmunotherapy
Speaker: Deng, Lei, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing, Beijing
4:45 PM - 6:00 PM PT

2352 - Evaluation of Factors Affecting Radiological Changes and Treatment Response Following LUNG Stereotactic Ablative Radiotherapy
Speaker: Dincbas, H. Fazilet, MD - Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul, Istanbul